|
|
||||||||
AJP - Renal Physiology, Vol 271, Issue 4 877-F885, Copyright © 1996 by American Physiological Society
ARTICLES |
L. Ibsen and K. Strange
Department of Medicine (Nephrology), Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Organic osmolytes accumulate in the mammalian brain when plasma osmolality is elevated chronically. An understanding of organic osmolyte regulation is important for elucidating the pathophysiology of numerous disease states, particularly those in which plasma osmolality is altered or manipulated. To this end, we have previously characterized the mechanisms of osmoregulatory myo-inositol accumulation and loss in rat brain glial cells. The validity of cell culture models of physiological functions, however, requires demonstration of similar behavior in vivo. We therefore examined the effect of serum hypertonicity and its correction on expression of the Na(+)-myo-inositol cotransporter (SMIT) in rat brain. Northern analysis revealed that chronic serum hypertonicity increased brain SMIT mRNA levels four- to sevenfold. Rapid reduction of serum osmolality caused a rapid fall in SMIT mRNA levels. In situ hybridization revealed a widespread distribution of cells expressing SMIT with striking regional variability in the number of and intensity of cells labeled. These results confirm and extend our studies of cultured glial cells and indicate that myo-inositol accumulation in vivo is due to increased expression of SMIT. Regional variability in the distribution of SMIT may be a factor in the differential vulnerability of certain brain regions to shifts in plasma osmolality.
This article has been cited by other articles:
![]() |
P. Bissonnette, K. Lahjouji, M. J. Coady, and J.-Y. Lapointe Effects of hyperosmolarity on the Na+-myo-inositol cotransporter SMIT2 stably transfected in the Madin-Darby canine kidney cell line Am J Physiol Cell Physiol, September 1, 2008; 295(3): C791 - C799. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Aouameur, S. Da Cal, P. Bissonnette, M. J. Coady, and J.-Y. Lapointe SMIT2 mediates all myo-inositol uptake in apical membranes of rat small intestine Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1300 - G1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bourgeois, M. J Coady, and J.-Y. Lapointe Determination of transport stoichiometry for two cation-coupled myo-inositol cotransporters: SMIT2 and HMIT J. Physiol., March 1, 2005; 563(2): 333 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Silver, B. M. Schroeder, and R. H. Sterns Brain Uptake of Myoinositol after Exogenous Administration J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1255 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Woo, S. C. Dahl, J. S. Handler, and H. M. Kwon Bidirectional regulation of tonicity-responsive enhancer binding protein in response to changes in tonicity Am J Physiol Renal Physiol, June 1, 2000; 278(6): F1006 - F1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Woo, D. Maouyo, J. S. Handler, and H. M. Kwon Nuclear redistribution of tonicity-responsive enhancer binding protein requires proteasome activity Am J Physiol Cell Physiol, February 1, 2000; 278(2): C323 - C330. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miyakawa, S. K. Woo, S. C. Dahl, J. S. Handler, and H. M. Kwon Tonicity-responsive enhancer binding protein, a Rel-like protein that stimulates transcription in response to hypertonicity PNAS, March 2, 1999; 96(5): 2538 - 2542. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Rim, M. G. Atta, S. C. Dahl, G. T. Berry, J. S. Handler, and H. M. Kwon Transcription of the Sodium/myo-Inositol Cotransporter Gene Is Regulated by Multiple Tonicity-responsive Enhancers Spread over 50 Kilobase Pairs in the 5'-Flanking Region J. Biol. Chem., August 7, 1998; 273(32): 20615 - 20621. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |